Loading…

Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease

Abstract Introduction: Cardiovascular disease is one of the main causes of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Autonomic dysfunction is associated with an increased risk for all cardiovascular events in the general population and can be eval...

Full description

Saved in:
Bibliographic Details
Published in:Kidney & blood pressure research 2019-10, Vol.44 (5), p.1142-1148
Main Authors: Lai, Silvia, Mangiulli, Marco, Perrotta, Adolfo M., Di Lazzaro Giraldi, Gianluca, Testorio, Massimo, Rosato, Edoardo, Cianci, Rosario, Gigante, Antonietta
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c625t-5d7d7eb06ec3b8993f5f0e873b47648e3f2ba9eaa1039c950781d7e88430a7693
cites cdi_FETCH-LOGICAL-c625t-5d7d7eb06ec3b8993f5f0e873b47648e3f2ba9eaa1039c950781d7e88430a7693
container_end_page 1148
container_issue 5
container_start_page 1142
container_title Kidney & blood pressure research
container_volume 44
creator Lai, Silvia
Mangiulli, Marco
Perrotta, Adolfo M.
Di Lazzaro Giraldi, Gianluca
Testorio, Massimo
Rosato, Edoardo
Cianci, Rosario
Gigante, Antonietta
description Abstract Introduction: Cardiovascular disease is one of the main causes of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Autonomic dysfunction is associated with an increased risk for all cardiovascular events in the general population and can be evaluated with heart rate variability (HRV). Objective: To evaluate HRV in ADPKD patients with mild hypertension versus hypertensive patients with organ damage and healthy controls (HC). Materials and Methods: We have enrolled 65 patients: 21 ADPKD patients (10 males), 20 patients with hypertension (14 males), and 24 HC (10 males). Biochemical analysis, clinical evaluation, anthropometric data, intima-media thickness, 24-h ECG Holter recording, and echocardiography were investigated at the time of enrollment. Results: No significant differences in HRV parameters were found between ADPKD with mild hypertension and hypertensive patients with organ damage. The median of HRV variables in time domain as SDNN (global autonomic activity) was significantly lower in ADPKD and hypertensive patients than HC (p < 0.05). In the frequency domain analysis, low frequency (LF), which mainly reflects the sympathetic component, showed higher values in ADPKD and hypertensive patients than HC during the night (p < 0.01). During the night, the sympathovagal balance, LF/high frequency (HF), showed higher values in ADPKD and hypertensive patients than HC (p < 0.0001). Conversely, LF day was lower in ADPKD and hypertensive patients than HC (p < 0.01). HF, which mainly reflects the parasympathetic component, was lower in ADPKD and hypertensive patients during the night than HC (p < 0.0001). Conclusions: HRV reduction is present in ADPKD patients with mild hypertension in the absence of organ damage. The evaluation of sympathovagal balance can provide novel information on the cardiovascular risk in ADPKD patients in addition to classical risk factors.
doi_str_mv 10.1159/000502419
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_31550720</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_15eb0b6eb627430c8d5c430bff071b05</doaj_id><sourcerecordid>3040489759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c625t-5d7d7eb06ec3b8993f5f0e873b47648e3f2ba9eaa1039c950781d7e88430a7693</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhSMEoqWwYI9QJDawCFy_4nhZ2kKrVgINj61lOzeVhySe2ski_77uzDBICLG6lv3dc3x0iuIlgfeECPUBAARQTtSj4phwyiognD3enqHioOqj4llK6y0G9GlxxIgQICkcF99W2M5u8mEs_VheoolTuTITlj9N9Mb63k_Lw8vpPIUUBtOX52Hwoxmn8mvoF7ekybvy2rcjLuW5T2gSPi-edKZP-GI_T4ofny6-n11WN18-X52d3lSupmKqRCtbiRZqdMw2SrFOdICNZJbLmjfIOmqNQmMIMOVU_nBD8kLTcAZG1oqdFFc73TaYtd5EP5i46GC83l6EeKtzHO961ERkI1ujranM665phcvTdh1IYkFkrbc7rU0MdzOmSQ8-Oex7M2KYk6ZUSUJrSmlG3_yFrsMcx5xUM-DAGyWF-h-Vm-KC14LzTL3bUS6GlCJ2hxgE9EO3-tBtZl_vFWc7YHsgf5f5x_KXibcYD8D1x9VOQm_aLlOv_kntXe4BkLKvwQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414546544</pqid></control><display><type>article</type><title>Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease</title><source>电子期刊和电子书数据库</source><creator>Lai, Silvia ; Mangiulli, Marco ; Perrotta, Adolfo M. ; Di Lazzaro Giraldi, Gianluca ; Testorio, Massimo ; Rosato, Edoardo ; Cianci, Rosario ; Gigante, Antonietta</creator><creatorcontrib>Lai, Silvia ; Mangiulli, Marco ; Perrotta, Adolfo M. ; Di Lazzaro Giraldi, Gianluca ; Testorio, Massimo ; Rosato, Edoardo ; Cianci, Rosario ; Gigante, Antonietta</creatorcontrib><description>Abstract Introduction: Cardiovascular disease is one of the main causes of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Autonomic dysfunction is associated with an increased risk for all cardiovascular events in the general population and can be evaluated with heart rate variability (HRV). Objective: To evaluate HRV in ADPKD patients with mild hypertension versus hypertensive patients with organ damage and healthy controls (HC). Materials and Methods: We have enrolled 65 patients: 21 ADPKD patients (10 males), 20 patients with hypertension (14 males), and 24 HC (10 males). Biochemical analysis, clinical evaluation, anthropometric data, intima-media thickness, 24-h ECG Holter recording, and echocardiography were investigated at the time of enrollment. Results: No significant differences in HRV parameters were found between ADPKD with mild hypertension and hypertensive patients with organ damage. The median of HRV variables in time domain as SDNN (global autonomic activity) was significantly lower in ADPKD and hypertensive patients than HC (p &lt; 0.05). In the frequency domain analysis, low frequency (LF), which mainly reflects the sympathetic component, showed higher values in ADPKD and hypertensive patients than HC during the night (p &lt; 0.01). During the night, the sympathovagal balance, LF/high frequency (HF), showed higher values in ADPKD and hypertensive patients than HC (p &lt; 0.0001). Conversely, LF day was lower in ADPKD and hypertensive patients than HC (p &lt; 0.01). HF, which mainly reflects the parasympathetic component, was lower in ADPKD and hypertensive patients during the night than HC (p &lt; 0.0001). Conclusions: HRV reduction is present in ADPKD patients with mild hypertension in the absence of organ damage. The evaluation of sympathovagal balance can provide novel information on the cardiovascular risk in ADPKD patients in addition to classical risk factors.</description><identifier>ISSN: 1420-4096</identifier><identifier>EISSN: 1423-0143</identifier><identifier>DOI: 10.1159/000502419</identifier><identifier>PMID: 31550720</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Adult ; Aged ; Anthropometry ; Autosomal dominant polycystic kidney disease ; Biochemical analysis ; Cardiovascular disease ; Cardiovascular diseases ; Cysts ; Damage assessment ; Echocardiography ; EKG ; Enrollments ; Female ; Fourier transforms ; Frequency analysis ; Frequency domain analysis ; Health risks ; Heart attacks ; Heart rate ; Heart Rate - physiology ; Heart rate variability ; Humans ; Hypertension ; Ischemia ; Kidney diseases ; Kidneys ; Male ; Males ; Middle Aged ; Morbidity ; Mortality ; Nervous system ; Night ; Nitric oxide ; Parasympathetic nervous system ; Pathogenesis ; Physiology ; Polycystic kidney ; Polycystic Kidney, Autosomal Dominant - physiopathology ; Reduction ; Research Article ; Risk analysis ; Risk factors ; Standard deviation ; Variability</subject><ispartof>Kidney &amp; blood pressure research, 2019-10, Vol.44 (5), p.1142-1148</ispartof><rights>2019 The Author(s) Published by S. Karger AG, Basel</rights><rights>2019 The Author(s) Published by S. Karger AG, Basel.</rights><rights>2019 The Author(s) Published by S. Karger AG, Basel . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c625t-5d7d7eb06ec3b8993f5f0e873b47648e3f2ba9eaa1039c950781d7e88430a7693</citedby><cites>FETCH-LOGICAL-c625t-5d7d7eb06ec3b8993f5f0e873b47648e3f2ba9eaa1039c950781d7e88430a7693</cites><orcidid>0000-0002-2015-765X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27635,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31550720$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lai, Silvia</creatorcontrib><creatorcontrib>Mangiulli, Marco</creatorcontrib><creatorcontrib>Perrotta, Adolfo M.</creatorcontrib><creatorcontrib>Di Lazzaro Giraldi, Gianluca</creatorcontrib><creatorcontrib>Testorio, Massimo</creatorcontrib><creatorcontrib>Rosato, Edoardo</creatorcontrib><creatorcontrib>Cianci, Rosario</creatorcontrib><creatorcontrib>Gigante, Antonietta</creatorcontrib><title>Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease</title><title>Kidney &amp; blood pressure research</title><addtitle>Kidney Blood Press Res</addtitle><description>Abstract Introduction: Cardiovascular disease is one of the main causes of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Autonomic dysfunction is associated with an increased risk for all cardiovascular events in the general population and can be evaluated with heart rate variability (HRV). Objective: To evaluate HRV in ADPKD patients with mild hypertension versus hypertensive patients with organ damage and healthy controls (HC). Materials and Methods: We have enrolled 65 patients: 21 ADPKD patients (10 males), 20 patients with hypertension (14 males), and 24 HC (10 males). Biochemical analysis, clinical evaluation, anthropometric data, intima-media thickness, 24-h ECG Holter recording, and echocardiography were investigated at the time of enrollment. Results: No significant differences in HRV parameters were found between ADPKD with mild hypertension and hypertensive patients with organ damage. The median of HRV variables in time domain as SDNN (global autonomic activity) was significantly lower in ADPKD and hypertensive patients than HC (p &lt; 0.05). In the frequency domain analysis, low frequency (LF), which mainly reflects the sympathetic component, showed higher values in ADPKD and hypertensive patients than HC during the night (p &lt; 0.01). During the night, the sympathovagal balance, LF/high frequency (HF), showed higher values in ADPKD and hypertensive patients than HC (p &lt; 0.0001). Conversely, LF day was lower in ADPKD and hypertensive patients than HC (p &lt; 0.01). HF, which mainly reflects the parasympathetic component, was lower in ADPKD and hypertensive patients during the night than HC (p &lt; 0.0001). Conclusions: HRV reduction is present in ADPKD patients with mild hypertension in the absence of organ damage. The evaluation of sympathovagal balance can provide novel information on the cardiovascular risk in ADPKD patients in addition to classical risk factors.</description><subject>Adult</subject><subject>Aged</subject><subject>Anthropometry</subject><subject>Autosomal dominant polycystic kidney disease</subject><subject>Biochemical analysis</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Cysts</subject><subject>Damage assessment</subject><subject>Echocardiography</subject><subject>EKG</subject><subject>Enrollments</subject><subject>Female</subject><subject>Fourier transforms</subject><subject>Frequency analysis</subject><subject>Frequency domain analysis</subject><subject>Health risks</subject><subject>Heart attacks</subject><subject>Heart rate</subject><subject>Heart Rate - physiology</subject><subject>Heart rate variability</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Ischemia</subject><subject>Kidney diseases</subject><subject>Kidneys</subject><subject>Male</subject><subject>Males</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Nervous system</subject><subject>Night</subject><subject>Nitric oxide</subject><subject>Parasympathetic nervous system</subject><subject>Pathogenesis</subject><subject>Physiology</subject><subject>Polycystic kidney</subject><subject>Polycystic Kidney, Autosomal Dominant - physiopathology</subject><subject>Reduction</subject><subject>Research Article</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Standard deviation</subject><subject>Variability</subject><issn>1420-4096</issn><issn>1423-0143</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>DOA</sourceid><recordid>eNp9kUtv1DAUhSMEoqWwYI9QJDawCFy_4nhZ2kKrVgINj61lOzeVhySe2ski_77uzDBICLG6lv3dc3x0iuIlgfeECPUBAARQTtSj4phwyiognD3enqHioOqj4llK6y0G9GlxxIgQICkcF99W2M5u8mEs_VheoolTuTITlj9N9Mb63k_Lw8vpPIUUBtOX52Hwoxmn8mvoF7ekybvy2rcjLuW5T2gSPi-edKZP-GI_T4ofny6-n11WN18-X52d3lSupmKqRCtbiRZqdMw2SrFOdICNZJbLmjfIOmqNQmMIMOVU_nBD8kLTcAZG1oqdFFc73TaYtd5EP5i46GC83l6EeKtzHO961ERkI1ujranM665phcvTdh1IYkFkrbc7rU0MdzOmSQ8-Oex7M2KYk6ZUSUJrSmlG3_yFrsMcx5xUM-DAGyWF-h-Vm-KC14LzTL3bUS6GlCJ2hxgE9EO3-tBtZl_vFWc7YHsgf5f5x_KXibcYD8D1x9VOQm_aLlOv_kntXe4BkLKvwQ</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Lai, Silvia</creator><creator>Mangiulli, Marco</creator><creator>Perrotta, Adolfo M.</creator><creator>Di Lazzaro Giraldi, Gianluca</creator><creator>Testorio, Massimo</creator><creator>Rosato, Edoardo</creator><creator>Cianci, Rosario</creator><creator>Gigante, Antonietta</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2015-765X</orcidid></search><sort><creationdate>20191001</creationdate><title>Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease</title><author>Lai, Silvia ; Mangiulli, Marco ; Perrotta, Adolfo M. ; Di Lazzaro Giraldi, Gianluca ; Testorio, Massimo ; Rosato, Edoardo ; Cianci, Rosario ; Gigante, Antonietta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c625t-5d7d7eb06ec3b8993f5f0e873b47648e3f2ba9eaa1039c950781d7e88430a7693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anthropometry</topic><topic>Autosomal dominant polycystic kidney disease</topic><topic>Biochemical analysis</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Cysts</topic><topic>Damage assessment</topic><topic>Echocardiography</topic><topic>EKG</topic><topic>Enrollments</topic><topic>Female</topic><topic>Fourier transforms</topic><topic>Frequency analysis</topic><topic>Frequency domain analysis</topic><topic>Health risks</topic><topic>Heart attacks</topic><topic>Heart rate</topic><topic>Heart Rate - physiology</topic><topic>Heart rate variability</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Ischemia</topic><topic>Kidney diseases</topic><topic>Kidneys</topic><topic>Male</topic><topic>Males</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Nervous system</topic><topic>Night</topic><topic>Nitric oxide</topic><topic>Parasympathetic nervous system</topic><topic>Pathogenesis</topic><topic>Physiology</topic><topic>Polycystic kidney</topic><topic>Polycystic Kidney, Autosomal Dominant - physiopathology</topic><topic>Reduction</topic><topic>Research Article</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Standard deviation</topic><topic>Variability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lai, Silvia</creatorcontrib><creatorcontrib>Mangiulli, Marco</creatorcontrib><creatorcontrib>Perrotta, Adolfo M.</creatorcontrib><creatorcontrib>Di Lazzaro Giraldi, Gianluca</creatorcontrib><creatorcontrib>Testorio, Massimo</creatorcontrib><creatorcontrib>Rosato, Edoardo</creatorcontrib><creatorcontrib>Cianci, Rosario</creatorcontrib><creatorcontrib>Gigante, Antonietta</creatorcontrib><collection>电子期刊和电子书数据库</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Kidney &amp; blood pressure research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lai, Silvia</au><au>Mangiulli, Marco</au><au>Perrotta, Adolfo M.</au><au>Di Lazzaro Giraldi, Gianluca</au><au>Testorio, Massimo</au><au>Rosato, Edoardo</au><au>Cianci, Rosario</au><au>Gigante, Antonietta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease</atitle><jtitle>Kidney &amp; blood pressure research</jtitle><addtitle>Kidney Blood Press Res</addtitle><date>2019-10-01</date><risdate>2019</risdate><volume>44</volume><issue>5</issue><spage>1142</spage><epage>1148</epage><pages>1142-1148</pages><issn>1420-4096</issn><eissn>1423-0143</eissn><abstract>Abstract Introduction: Cardiovascular disease is one of the main causes of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Autonomic dysfunction is associated with an increased risk for all cardiovascular events in the general population and can be evaluated with heart rate variability (HRV). Objective: To evaluate HRV in ADPKD patients with mild hypertension versus hypertensive patients with organ damage and healthy controls (HC). Materials and Methods: We have enrolled 65 patients: 21 ADPKD patients (10 males), 20 patients with hypertension (14 males), and 24 HC (10 males). Biochemical analysis, clinical evaluation, anthropometric data, intima-media thickness, 24-h ECG Holter recording, and echocardiography were investigated at the time of enrollment. Results: No significant differences in HRV parameters were found between ADPKD with mild hypertension and hypertensive patients with organ damage. The median of HRV variables in time domain as SDNN (global autonomic activity) was significantly lower in ADPKD and hypertensive patients than HC (p &lt; 0.05). In the frequency domain analysis, low frequency (LF), which mainly reflects the sympathetic component, showed higher values in ADPKD and hypertensive patients than HC during the night (p &lt; 0.01). During the night, the sympathovagal balance, LF/high frequency (HF), showed higher values in ADPKD and hypertensive patients than HC (p &lt; 0.0001). Conversely, LF day was lower in ADPKD and hypertensive patients than HC (p &lt; 0.01). HF, which mainly reflects the parasympathetic component, was lower in ADPKD and hypertensive patients during the night than HC (p &lt; 0.0001). Conclusions: HRV reduction is present in ADPKD patients with mild hypertension in the absence of organ damage. The evaluation of sympathovagal balance can provide novel information on the cardiovascular risk in ADPKD patients in addition to classical risk factors.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>31550720</pmid><doi>10.1159/000502419</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2015-765X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1420-4096
ispartof Kidney & blood pressure research, 2019-10, Vol.44 (5), p.1142-1148
issn 1420-4096
1423-0143
language eng
recordid cdi_pubmed_primary_31550720
source 电子期刊和电子书数据库
subjects Adult
Aged
Anthropometry
Autosomal dominant polycystic kidney disease
Biochemical analysis
Cardiovascular disease
Cardiovascular diseases
Cysts
Damage assessment
Echocardiography
EKG
Enrollments
Female
Fourier transforms
Frequency analysis
Frequency domain analysis
Health risks
Heart attacks
Heart rate
Heart Rate - physiology
Heart rate variability
Humans
Hypertension
Ischemia
Kidney diseases
Kidneys
Male
Males
Middle Aged
Morbidity
Mortality
Nervous system
Night
Nitric oxide
Parasympathetic nervous system
Pathogenesis
Physiology
Polycystic kidney
Polycystic Kidney, Autosomal Dominant - physiopathology
Reduction
Research Article
Risk analysis
Risk factors
Standard deviation
Variability
title Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T05%3A19%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20in%20Heart%20Rate%20Variability%20in%20Autosomal%20Dominant%20Polycystic%20Kidney%20Disease&rft.jtitle=Kidney%20&%20blood%20pressure%20research&rft.au=Lai,%20Silvia&rft.date=2019-10-01&rft.volume=44&rft.issue=5&rft.spage=1142&rft.epage=1148&rft.pages=1142-1148&rft.issn=1420-4096&rft.eissn=1423-0143&rft_id=info:doi/10.1159/000502419&rft_dat=%3Cproquest_pubme%3E3040489759%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c625t-5d7d7eb06ec3b8993f5f0e873b47648e3f2ba9eaa1039c950781d7e88430a7693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2414546544&rft_id=info:pmid/31550720&rfr_iscdi=true